Clinical Trial Update: Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ivabradine on cardiovascular events in chronic heart failure with left ventricular systolic dysfunction has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Chronic Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2015-06-29